NCT05378490 The Akershus Study of Ischemic Stroke and Thrombolysis -1
| NCT ID | NCT05378490 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Akershus |
| Condition | Stroke, Acute |
| Study Type | OBSERVATIONAL |
| Enrollment | 6,000 participants |
| Start Date | 2012-01-01 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 6,000 participants in total. It began in 2012-01-01 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This observational study comprises consecutively patients with cerebrovascular diseases admitted to the Stroke Unit at Akershus University Hospital in Norway. Akershus University Hospital is the largest emergency care hospital in Norway and has a catchment area covering a population of 550.000, which is approximately 10 % of the Norwegian population and reasonably representative according to data from Statistics Norway. The hospital is public and serving both as a primary hospital and a university hospital. Due to the Norwegian, national, all-covering health-insurance, all patients enter the hospital and are considered for further in-patient care on the same conditions. The hospital has a stroke unit classified as a comprehensive stroke center according to European Stroke Organisation standards. Acute stroke management follows national and international guidelines. Overall, the ASIST-1 study will investigate management, outcome and prognosis of stroke and stroke care pathways and later follow up in primary care using several approaches combining existing clinical data from a representative population with different Norwegian health registries. Parts of the study are retrospective with prospective follow-up by health registries and parts of the study are prospective.
Eligibility Criteria
Inclusion Criteria: * Cerebrovascular diseases (acute ischemic stroke, intracerebral hemorrhage, transient ischemic attack) or stroke mimics Exclusion Criteria: * None
Contact & Investigator
Espen S. Kristoffersen, MD, PhD
✉ e.s.kristoffersen@medisin.uio.noEspen S. Kristoffersen, MD, PhD
PRINCIPAL INVESTIGATOR
University Hospital, Akershus
Frequently Asked Questions
Who can join the NCT05378490 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Stroke, Acute. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05378490 currently recruiting?
Yes, NCT05378490 is actively recruiting participants. Contact the research team at e.s.kristoffersen@medisin.uio.no for enrollment information.
Where is the NCT05378490 trial being conducted?
This trial is being conducted at Lørenskog, Norway.
Who is sponsoring the NCT05378490 clinical trial?
NCT05378490 is sponsored by University Hospital, Akershus. The principal investigator is Espen S. Kristoffersen, MD, PhD at University Hospital, Akershus. The trial plans to enroll 6,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.